EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Dysregulation of iron metabolism in chronic kidney disease – hepcidin as a diagnostic biomarker in Iraqi adults – a case-control study

Mohammed Abdul Jaleel Tarweel, Haider Abd Jabber Alammar

European Journal of Clinical and Experimental Medicine · 30.03.2026 · 24 (1) · 15-22

DOI: 10.15584/ejcem.2026.1.4 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift European Journal of Clinical and Experimental Medicine, online erschienen am 30.03.2026. Verfasst von Mohammed Abdul Jaleel Tarweel und 1 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and aim. Chronic kidney disease (CKD) is a global health burden, with iron deficiency (ID) being a prevalent but under-diagnosed comorbidity. Traditional biomarkers, such as serum ferritin and transferrin saturation, are confounded by inflammation, which limits diagnostic accuracy. Hepcidin, a key regulator of iron homeostasis, offers potential as a reliable biomarker; however, data from low- and middle-income countries (LMICs), including Iraq, remain scarce. This study assessed the diagnostic utility of hepcidin for CKD and its association with iron dysregulation in Iraqi adults, addressing regional gaps in biomarker validation and clinical application. Material and methods. This case-control study (September 2024–February 2025) recruited 60 patients with CKD (stages 2–4) and 40 age-and sex-matched healthy controls. The exclusion criteria were recent transfusions, infections, or iron therapy. Serum hepcidin, ferritin, iron, Total Iron-Binding Capacity (TIBC), transferrin, and renal function indices were analyzed via enzyme-linked immunosorbent assay and standardized assays. Results. CKD patients exhibited significantly elevated hepcidin (39.8±23.1 vs. 13.7±4.8 pg/mL, p

Zitieren

APA

Tarweel, M. A. J., & Alammar, H. A. J. (2026). Dysregulation of iron metabolism in chronic kidney disease – hepcidin as a diagnostic biomarker in Iraqi adults – a case-control study. European Journal of Clinical and Experimental Medicine, 24(1), 15-22. https://doi.org/10.15584/ejcem.2026.1.4

Vancouver

Tarweel MAJ, Alammar HAJ. Dysregulation of iron metabolism in chronic kidney disease – hepcidin as a diagnostic biomarker in Iraqi adults – a case-control study. European Journal of Clinical and Experimental Medicine. 2026;24(1):15-22. doi:10.15584/ejcem.2026.1.4

BibTeX
@article{Tarweel2026,
  author = {Tarweel, Mohammed Abdul Jaleel and Alammar, Haider Abd Jabber},
  title = {Dysregulation of iron metabolism in chronic kidney disease – hepcidin as a diagnostic biomarker in Iraqi adults – a case-control study},
  journal = {European Journal of Clinical and Experimental Medicine},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {15--22},
  doi = {10.15584/ejcem.2026.1.4}
}
Kostenlos starten →